Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
How Kansas City’s new airport terminal became a sprawling art gallery for 28 diverse creatives
Every major milestone in Kathy Minhsin Liao’s life has been marked by travel, she shared, making airports synonymous with transition. “My [art]work at the new terminal is called ‘Hello and Goodbye,’ and it touches on my personal experience of the fluidity of travel. When you’re at the airport, you’re in that limbo space of thinking…
$2M in federal funds secured for Disney’s forgotten ‘cradle of Hollywood animation’ in KC
A decades-long effort to redevelop Walt Disney’s original Laugh-O-gram animation studios at 31st and Forest, along the Troost corridor, will receive $2 million in federal funding, as officially announced last week by Congressman Emanuel Cleaver II. The influx of funding should generate “momentum” to raise the remaining money needed to complete the project, said Gary…
KC’s Westside neighborhood awarded $1M from feds to reconnect community split by I-35
A newly announced $1 million grant is expected to help reestablish a Kansas City neighborhood that was cut off from itself and opportunity thanks to past transportation infrastructure decisions — part of a $1 billion plan to right what many call a decades-long wrong largely perpetrated against historic communities of color. In a first round…
‘Work to support our innovators is never done’: NXTUS leadership transition follows massive impact expansion
WICHITA — NXTUS, a nonprofit working to connect startup founders with community resources, capital and customers, on Tuesday announced a top-level leadership change while celebrating milestones in the rollout of its work to help innovators and entrepreneurs grow “companies of significance” in Kansas. Mary Beth Jarvis, who joined Wichita-based NXTUS as executive director in August 2019,…